Client
Pharma company
Respondents
n=20 people
who recently started new medication
Used community to quickly identify early adopters for new injectable
Methods
Telephone interviews
Experience with new medication
Suggested Articles
Endocrinologist Perspectives: Oral and Injectable Therapies
dQ&A conducted another wave of our Endocrinologist Perspectives research with n=190 endocrinologists across private offices, hospitals, community clinics, and managed care organizations. Results indicated that…
dQ&A® and CeQur Publication Featured in Clinical Diabetes
Transition to the SIP…
Findings from Diabetes Technology in Primary Care Research
In December 2022…
